Evidence map›Paper›PMID 35659231›Full record

Trial reportMalaria journal2022

Impact of a spatial repellent product on Anopheles and non-Anopheles mosquitoes in Sumba, Indonesia.

Dendi H Permana, Siti Zubaidah, Lepa Syahrani, Puji B S Asih, Din Syafruddin, Ismail E Rozi, Anggi P N Hidayati, Sully Kosasih, Farahana K Dewayanti, Nia Rachmawati and 11 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Malaria journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 3 countries.

Dendi H Permana *Eijkman Institute for Molecular Biology, National Research and Innovation Agency, Diponegoro 69, Jakarta Pusat, 10430, Indonesia.
Siti Zubaidah *Eijkman Institute for Molecular Biology, National Research and Innovation Agency, Diponegoro 69, Jakarta Pusat, 10430, Indonesia.
Lepa Syahrani *Eijkman Institute for Molecular Biology, National Research and Innovation Agency, Diponegoro 69, Jakarta Pusat, 10430, Indonesia.
Puji B S AsihEijkman Institute for Molecular Biology, National Research and Innovation Agency, Diponegoro 69, Jakarta Pusat, 10430, Indonesia.
Din SyafruddinEijkman Institute for Molecular Biology, National Research and Innovation Agency, Diponegoro 69, Jakarta Pusat, 10430, Indonesia. dinkarim@yahoo.com.ORCID http://orcid.org/0000-0001-7141-2545
Ismail E RoziEijkman Institute for Molecular Biology, National Research and Innovation Agency, Diponegoro 69, Jakarta Pusat, 10430, Indonesia.
Anggi P N HidayatiEijkman Institute for Molecular Biology, National Research and Innovation Agency, Diponegoro 69, Jakarta Pusat, 10430, Indonesia.
Sully KosasihEijkman Institute for Molecular Biology, National Research and Innovation Agency, Diponegoro 69, Jakarta Pusat, 10430, Indonesia.
Farahana K DewayantiEijkman Institute for Molecular Biology, National Research and Innovation Agency, Diponegoro 69, Jakarta Pusat, 10430, Indonesia.
Nia RachmawatiEijkman Institute for Molecular Biology, National Research and Innovation Agency, Diponegoro 69, Jakarta Pusat, 10430, Indonesia.
Rifqi RisandiEijkman Institute for Molecular Biology, National Research and Innovation Agency, Diponegoro 69, Jakarta Pusat, 10430, Indonesia.
Michael J BangsPublic Health and Malaria Control, PT Freeport Indonesia, International SOS, Kuala Kencana, Papua, Indonesia.
Claus BøghThe Sumba Foundation, Public Health and Malaria Control, Bali, Indonesia.
Jenna R DavidsonDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, USA.
Allison L HendershotDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, USA.
Timothy A BurtonDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, USA.
John P GriecoDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, USA.
Evercita C EugenioSandia National Laboratories, Albuquerque, NM, USA.
Fang LiuDepartment of Applied and Computational Mathematics and Statistics, University of Notre Dame, Notre Dame, IN, USA.
Nicole L AcheeDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, USA.
Neil F LoboDepartment of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, USA.
Eijkman Institute for Molecular Biology · IDUniversity of Notre Dame · USKasetsart University · THSandia National Laboratories · US

Funding

Bill and Melinda Gates Foundation Award Number: OPP1081737Bill and Melinda Gates Foundation OPP1081737Kementerian Riset Teknologi Dan Pendidikan Tinggi Republik Indonesia
6 · The paper itself

Abstract

backgroundThe East Nusa Tenggara province, Indonesia, contributed to 5% of malaria cases nationally in 2020, with other mosquito-borne diseases, such as dengue and filariasis also being endemic. Monitoring of spatial and temporal vector species compositions and bionomic traits is an efficient method for generating evidence towards intervention strategy optimization and meeting disease elimination goals.

methodsThe impact of a spatial repellent (SR) on human biting mosquitoes was evaluated as part of a parent cluster-randomized, double-blinded, placebo-controlled trial, in Sumba, East Nusa Tenggara. A 10-month (June 2015-March 2016) baseline study was followed by a 24-month intervention period (April 2016 to April 2018)-where half the clusters were randomly assigned either a passive transfluthrin emanator or a placebo control.

resultsHuman-landing mosquito catches documented a reduction in landing rates related to the SR. Overall, there was a 16.4% reduction (21% indoors, and 11.3% outdoors) in human biting rates (HBR) for Anopheles. For Aedes, there was a 44.3% HBR reduction indoors and a 35.6% reduction outdoors. This reduction was 38.3% indoors and 39.1% outdoors for Armigeres, and 36.0% indoors and 32.3% outdoors for Culex species. Intervention impacts on the HBRs were not significant and are attributed to large inter-household and inter cluster variation. Anopheles flavirostris, Anopheles balabacensis and Anopheles maculatus individually impacted the overall malaria infections hazard rate with statistically significance. Though there was SR-based protection against malaria for all Anopheles species (except Anopheles sundaicus), only five (Anopheles aconitus, Anopheles kochi, Anopheles tessellatus, An. maculatus and An. sundaicus) demonstrated statistical significance. The SR numerically reduced Anopheles parity rates indoors and outdoors when compared to the placebo.

conclusionEvidence demonstrating that Anopheles vectors bite both indoors and outdoors indicates that currently implemented indoor-based vector control tools may not be sufficient to eliminate malaria. The documented impact of the SR intervention on Aedes, Armigeres and Culex species points to its importance in combatting other vector borne diseases. Studies to determine the impact of spatial repellents on other mosquito-borne diseases is recommended.

Indexed as

AedesAnophelesCulexInsect RepellentsMalariaAnimalsHumansIndonesiaMosquito ControlMosquito VectorsInsect RepellentsAnophelesAnthropophagicIndonesiaMosquitoesSpatial repellentSumba

Identifiers

PMID35659231
PMCPMC9166507
OpenAlexW4281932453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.